Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Raw Materials (2017 - 2026)

Dexcom has reported Raw Materials over the past 13 years, most recently at $247.9 million for Q1 2026.

  • Quarterly Raw Materials fell 32.27% to $247.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $247.9 million through Mar 2026, down 32.27% year-over-year, with the annual reading at $257.6 million for FY2025, 21.25% down from the prior year.
  • Raw Materials was $247.9 million for Q1 2026 at Dexcom, down from $257.6 million in the prior quarter.
  • Over five years, Raw Materials peaked at $366.0 million in Q1 2025 and troughed at $151.1 million in Q2 2022.
  • The 5-year median for Raw Materials is $257.6 million (2025), against an average of $254.0 million.
  • Year-over-year, Raw Materials soared 100.94% in 2023 and then crashed 32.27% in 2026.
  • A 5-year view of Raw Materials shows it stood at $159.0 million in 2022, then soared by 100.94% to $319.5 million in 2023, then grew by 2.38% to $327.1 million in 2024, then fell by 21.25% to $257.6 million in 2025, then decreased by 3.77% to $247.9 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Raw Materials are $247.9 million (Q1 2026), $257.6 million (Q4 2025), and $266.0 million (Q3 2025).